rs373082402
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000626.4(CD79B):c.250G>A(p.Glu84Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000483 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000626.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD79B | NM_000626.4 | c.250G>A | p.Glu84Lys | missense_variant | 3/6 | ENST00000006750.8 | NP_000617.1 | |
CD79B | NM_001039933.3 | c.253G>A | p.Glu85Lys | missense_variant | 3/6 | NP_001035022.1 | ||
CD79B | NM_001329050.2 | c.122-366G>A | intron_variant | NP_001315979.1 | ||||
CD79B | NM_021602.4 | c.119-366G>A | intron_variant | NP_067613.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD79B | ENST00000006750.8 | c.250G>A | p.Glu84Lys | missense_variant | 3/6 | 1 | NM_000626.4 | ENSP00000006750.4 | ||
ENSG00000285947 | ENST00000647774.1 | c.50-366G>A | intron_variant | ENSP00000497443.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251400Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135890
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461858Hom.: 0 Cov.: 34 AF XY: 0.0000371 AC XY: 27AN XY: 727238
GnomAD4 genome AF: 0.000138 AC: 21AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74362
ClinVar
Submissions by phenotype
Agammaglobulinemia 6, autosomal recessive Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 14, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 06, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 84 of the CD79B protein (p.Glu84Lys). This variant is present in population databases (rs373082402, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with CD79B-related conditions. ClinVar contains an entry for this variant (Variation ID: 567186). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at